Zurich Cantonal Bank’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-15,482
| Closed | -$11K | – | 2890 |
|
2022
Q1 | $11K | Hold |
15,482
| – | – | ﹤0.01% | 2700 |
|
2021
Q4 | $35K | Hold |
15,482
| – | – | ﹤0.01% | 2805 |
|
2021
Q3 | $45K | Hold |
15,482
| – | – | ﹤0.01% | 2643 |
|
2021
Q2 | $59K | Hold |
15,482
| – | – | ﹤0.01% | 2413 |
|
2021
Q1 | $52K | Hold |
15,482
| – | – | ﹤0.01% | 2370 |
|
2020
Q4 | $43K | Hold |
15,482
| – | – | ﹤0.01% | 2468 |
|
2020
Q3 | $39K | Hold |
15,482
| – | – | ﹤0.01% | 2323 |
|
2020
Q2 | $210K | Buy |
15,482
+9,703
| +168% | +$132K | ﹤0.01% | 1483 |
|
2020
Q1 | $44K | Hold |
5,779
| – | – | ﹤0.01% | 1988 |
|
2019
Q4 | $37K | Hold |
5,779
| – | – | ﹤0.01% | 2293 |
|
2019
Q3 | $23K | Hold |
5,779
| – | – | ﹤0.01% | 2405 |
|
2019
Q2 | $28K | Hold |
5,779
| – | – | ﹤0.01% | 2345 |
|
2019
Q1 | $47K | Sell |
5,779
-2,033
| -26% | -$16.5K | ﹤0.01% | 2043 |
|
2018
Q4 | $43K | Buy |
7,812
+2,835
| +57% | +$15.6K | ﹤0.01% | 2117 |
|
2018
Q3 | $44K | Hold |
4,977
| – | – | ﹤0.01% | 2219 |
|
2018
Q2 | $50K | Buy |
4,977
+2,876
| +137% | +$28.9K | ﹤0.01% | 2124 |
|
2018
Q1 | $20K | Buy |
+2,101
| New | +$20K | ﹤0.01% | 2410 |
|